ACTHREL

Brand name authorized in: United Kingdom United States

Active ingredients

The drug ACTHREL contains one active pharmaceutical ingredient (API):

1 Corticorelin
UNII 56X54T817Q - CORTICORELIN OVINE TRIFLUTATE

Corticorelin results in a rapid and sustained increase of plasma ACTH levels and a near parallel increase of plasma cortisol. In addition corticorelin causes a concomitant and prolonged release of the related proopiomelanocortin peptides β- and γ-lipotropins (β- and γ-LPH) and β-endorphin (β-END).

Read about Corticorelin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
H01AA01
Corticotropin
H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01A Anterior pituitary lobe hormones and analogues → H01AA ACTH
Discover more medicines within H01AA01

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
ACTHREL Powder for solution for injection
Structured product labeling (SPL)
US

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 326208
US
FDA, National Drug Code
Identifier(s): 55566-0302